U.S. Healthtech Stock News

With inflation readings mixed, interest rate paths diverging and energy markets keeping everyone on edge, many investors are looking beyond the mega cap AI leaders and towards smaller stocks that are still shaping the future of machine learning, automation and data intelligence. The AI Small Caps screener focuses on these early stage companies, where new products and business models can have a meaningful impact on growth potential. In this article, you will see 3 stocks from the screener that...

In late June 2026, Centrus Energy Corp. was removed from multiple Russell indexes, including the Russell 3000E and Russell Microcap and their associated growth and value benchmarks, following the index provider’s annual rebalancing. At the same time, Centrus secured a Letter of Intent to supply domestic HALEU to Oklo Inc. for up to five Aurora powerhouses and gained shareholder approval to add officer exculpation protections, signaling both commercial momentum in advanced nuclear fuel and a...

In its Q1 2026 investor letter, Madison Investments reported that THOR Industries was among its bottom five detractors, citing pressure on RV demand from higher oil prices and interest rates linked to the Iran war. The commentary underscores how sensitive THOR Industries’ business is to macroeconomic shocks, as shifts in travel costs and borrowing conditions quickly filter through to RV sales expectations. Against this backdrop of macro-driven pressure on RV demand, we will examine how these...

Ubiquiti stock: event driven interest Recent commentary highlighting Ubiquiti (UI) as a potential beneficiary of IoT growth, fiber densification, 5G, and cloud infrastructure trends, along with upward revisions to earnings estimates, has renewed attention on how the stock is priced. See our latest analysis for Ubiquiti. Against that backdrop, Ubiquiti’s share price has recently come under pressure, with the stock down 2.14% over one day, 5.15% over seven days, 8.53% over 30 days, and 35.11%...

TopBuild stock has delivered a strong 87.2% return over the past five years, yet its recent pullback and the current valuation checks point to a more nuanced picture. The Discounted Cash Flow (DCF) intrinsic value estimate indicates the shares may trade below that modeled value, while market multiples look closer to fair. Over five years, TopBuild has returned 87.2%, which sets a high bar for any further upside to be justified by fundamentals. The pending merger with QXO, including the...

Recent Stock Move Puts Cleveland-Cliffs Under The Microscope Cleveland-Cliffs (CLF) drew attention after its stock declined 5.73% in the latest session, as investors looked ahead to an upcoming quarterly report that is expected to show earnings per share of a $0.18 loss. See our latest analysis for Cleveland-Cliffs. The latest drop comes after a tougher stretch for Cleveland-Cliffs, with a 7 day share price return of down 15.86% and a 30 day share price return of down 30.96%. However, the 90...

On June 27, 2026, Atlanticus Holdings Corporation (NasdaqGS: ATLC) was removed from several Russell value and small-cap benchmarks, including the Russell 2000 Value and Russell 3000 Value indices, following the annual index reconstitution. This cluster of index removals can matter to investors because index-tracking funds may adjust their positions, potentially changing liquidity patterns and who holds the stock. We’ll now examine how Atlanticus’s simultaneous removal from multiple Russell...

DHT Holdings plans design upgrades for two Hyundai newbuildings scheduled for 2026 delivery. DHT Impala is set for early delivery with enhanced trading eligibility features. DHT intends to upgrade DHT Gazelle to a similar specification while keeping charter commitments intact. For investors watching NYSE:DHT, these vessel design moves arrive alongside a share price of $16.53 and a long run of strong returns. The stock is up 40.8% year to date and 68.6% over the past year, with a gain of...

Shake Shack Canada recently announced plans for its first Alberta drive-thru at 9253 Macleod Trail Southwest, expected to open in fall 2026 and contribute to roughly 200 local jobs once its Alberta locations are fully operating. This expansion comes as Shake Shack’s latest earnings season highlighted revenue growth but also revealed a miss on key profitability measures, sharpening investor focus on how new formats like drive-thrus might influence future performance. We’ll now explore how the...

Super Micro Computer’s stock has swung sharply in recent months, yet current valuation checks point in the same direction. Both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggest the shares trade below what the fundamentals imply. Super Micro Computer has delivered a very large 5 year return of about 7x, which sets a high bar for what counts as attractive value today. Expectations around continued AI server demand and a sizable order backlog can support the...

The renewed access to Anthropic’s Claude Fable 5 and Mythos 5 models, alongside a tougher U.S. regulatory stance on AI, is reshaping how investors look at cloud and enterprise software stocks linked to AI workloads and compliance needs. With export controls lifted, some U.S. AI driven cloud and enterprise software providers are again positioned to build on Anthropic’s latest tools, even as regulatory uncertainty lingers. This article looks at 3 stocks from our U.S. AI Driven Cloud and...

Snap-on (SNA) is back in focus after recent share price gains, with the stock closing at $402.40. Investors are weighing this move against the company’s steady tools, equipment, and diagnostics business model. See our latest analysis for Snap-on. Viewed in context, the recent 1-day share price return of 1.01% and 30-day share price return of 8.40% sit on top of a 1-year total shareholder return of 30.09%, indicating that momentum in Snap-on has been building rather than fading. If Snap-on’s...

Dianthus Therapeutics has initiated the global, randomized, placebo-controlled Phase 3 EMERGE trial of its investigational antibody claseprubart in generalized Myasthenia Gravis, following encouraging Phase 2 MaGic data and recent FDA Orphan Drug Designation for this indication. By targeting only the active form of C1s in the classical complement pathway with an infrequently dosed subcutaneous formulation, claseprubart aims to balance efficacy, infection risk, and convenience for gMG...

HealthEquity stock moves after index removal and stock offering plans HealthEquity (HQY) has drawn fresh attention after being removed from the Russell 2000 Dynamic Index and filing a US$204.8 million shelf registration for common stock tied to an employee stock ownership plan. For investors following HealthEquity, these two developments sit squarely at the intersection of index related flows and potential equity issuance. Both factors can influence liquidity, trading volumes and how the...

Index additions put Guardian Pharmacy Services in focus Guardian Pharmacy Services (GRDN) has drawn fresh attention after being added to the Russell 2000 Defensive Index and the Russell 2000 Growth Defensive Index, highlighting how index inclusion can influence investor interest and liquidity. See our latest analysis for Guardian Pharmacy Services. Guardian Pharmacy Services has seen buying interest build over the past year, with a 1-year total shareholder return of 95.65% and a year to date...

Why Kilroy Realty Stock Is Back in Focus After a Major Credit Rework Kilroy Realty (KRC) shares are drawing attention after the company closed amended senior unsecured revolving credit and term loan facilities, expanding available borrowing capacity and pushing key debt maturities further into the next decade. See our latest analysis for Kilroy Realty. Against this credit backdrop, Kilroy Realty’s share price has risen 9.34% over the past month and 33.44% over the past 90 days, while its 1...

Federated Hermes (FHI) has drawn fresh attention after launching two actively managed ETFs, including the Ultrashort Bond ETF targeting investment grade debt and the International Leaders ETF focusing on developed market equities. See our latest analysis for Federated Hermes. These ETF launches come as Federated Hermes shares trade at US$55.22. The stock is down over the past week and quarter, but is supported by a positive year to date share price return and strong multi year total...

Harmony Biosciences has recently outlined plans to expand beyond its core sleep drug Wakix by advancing pitolisant into new indications, developing high-dose and gastro-resistant formulations, and progressing additional neuroscience assets such as an orexin-2 receptor agonist and rare epilepsy programs. This push to diversify its portfolio suggests Harmony is working to reduce its reliance on a single product and build a broader neuroscience franchise across sleep and rare neurological...

Hilltop Holdings (HTH) is back in focus after affiliate Momentum Independent Network launched Momentum Financial Institution Services to offer brokerage, advisory, and consulting support tailored to smaller community banks and credit unions. See our latest analysis for Hilltop Holdings. Hilltop Holdings’ share price has a year to date return of 14.40% and a 90 day share price return of 7.75% at a last close of $38.78, while the 1 year total shareholder return of 26.50% points to momentum that...

On 27 June 2026, Precigen, Inc. (NasdaqGS:PGEN) was removed from several Russell value indexes, including the Russell 2000, 2500, 3000, 3000E, Small Cap, and Microcap Value benchmarks. This broad index removal can prompt portfolio rebalancing by passive funds, potentially reshaping who holds the stock and how it trades over time. We’ll now examine how Precigen’s removal from multiple Russell value benchmarks may influence its investment narrative and future investor focus. The future of work...

Why the latest index moves matter for Analog Devices Analog Devices (ADI) is back in focus after a series of index changes and recent earnings, with the stock joining several Russell growth benchmarks while exiting certain defensive and value oriented indices. These moves follow Q2 2026 results that were supported by the Industrial Business segment and Q3 guidance with revenue and adjusted EPS targets above analyst expectations, prompting some investors to reconsider how they classify Analog...

The current AI boom has pushed high profile stocks such as Caterpillar into the spotlight, with Michael Burry publicly betting against what he sees as stretched valuations. When big investors question the durability of an AI driven rally, it can be a useful moment to look at steadier ideas that rely less on market excitement. This article focuses on defensive value stocks that combine lower volatility with reasonable pricing and dividend potential. You will see 3 stocks from this screener...

Pagaya Technologies recently saw CEO Gal Krubiner buy 16,230 shares on the open market, while the company upsized a US$800 million, AAA-rated personal loan asset-backed securities deal and expanded its partnership with Upgrade to power buy now, pay later offerings at the point of sale. Together, these moves highlight how Pagaya is deepening its role in consumer credit infrastructure by pairing AI-driven underwriting with large-scale capital markets funding and embedded lending...

RB Global (RBA) has been removed from several Russell growth benchmarks, a shift that can influence trading flows as index tracking funds adjust positions and active managers reassess exposure. See our latest analysis for RB Global. At a share price of $116.45, RB Global has seen firm upward momentum recently, with a 7 day share price return of 7.37% and a 90 day share price return of 20.55%, while the 5 year total shareholder return of 115.53% points to strong longer term compounding. Index...